{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T10:28:27Z","timestamp":1760783307271},"reference-count":119,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2010,8,26]],"date-time":"2010-08-26T00:00:00Z","timestamp":1282780800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1007\/s10549-010-1124-4","type":"journal-article","created":{"date-parts":[[2010,8,25]],"date-time":"2010-08-25T04:40:47Z","timestamp":1282711247000},"page":"369-378","source":"Crossref","is-referenced-by-count":11,"title":["The management of ductal intraepithelial neoplasia (DIN): open controversies and guidelines of the Istituto Europeo di Oncologia (IEO), Milan, Italy"],"prefix":"10.1007","volume":"128","author":[{"given":"Gabriel","family":"Farante","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Zurrida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viviana","family":"Galimberti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Veronesi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Curigliano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Luini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aron","family":"Goldhirsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Umberto","family":"Veronesi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,8,26]]},"reference":[{"key":"1124_CR1","first-page":"140","volume":"11","author":"FA Tavassoli","year":"1998","unstructured":"Tavassoli FA (1998) Ductal carcinoma in situ: introduction of the concept of ductal intraepithelial neoplasia. Mod Pathol 11:140\u2013154","journal-title":"Mod Pathol"},{"key":"1124_CR2","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1016\/S0140-6736(05)66546-4","volume":"365","author":"U Veronesi","year":"2005","unstructured":"Veronesi U, Boyle P, Goldhirsch A et al (2005) Breast cancer. Lancet 365:1727\u20131741","journal-title":"Lancet"},{"key":"1124_CR3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.breast.2005.11.011","volume":"15","author":"U Veronesi","year":"2006","unstructured":"Veronesi U, Viale G, Rotmenz N et al (2006) Rethinking TNM: breast cancer TNM classification for treatment decision-making and research. Breast 15:3\u20138","journal-title":"Breast"},{"key":"1124_CR4","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1093\/jnci\/djp482","volume":"102","author":"B Virnig","year":"2010","unstructured":"Virnig B, Tuttle T, Shamliyan T et al (2010) Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment and outcomes. J Natl Cancer Inst 102:170\u2013178","journal-title":"J Natl Cancer Inst"},{"key":"1124_CR5","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1093\/jnci\/djh069","volume":"96","author":"NN Baxter","year":"2004","unstructured":"Baxter NN, Virnig BA, Durham SB et al (2004) Trends in the treatment of ductal carcinoma in situ of the breast. J Natl Cancer Inst 96:443\u2013448","journal-title":"J Natl Cancer Inst"},{"key":"1124_CR6","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1001\/jama.275.12.913","volume":"275","author":"VL Ernster","year":"1996","unstructured":"Ernster VL, Barclay J, Kerlikowske K et al (1996) Incidence of and treatment for ductal carcinoma in situ of the breast. JAMA 275:913\u2013918","journal-title":"JAMA"},{"key":"1124_CR7","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1002\/cncr.20580","volume":"101","author":"E Ceilley","year":"2004","unstructured":"Ceilley E, Jagsi R, Goldberg S et al (2004) The management of ductal carcinoma in situ in North America and Europe results of a survey. Cancer 101:1958\u20131967","journal-title":"Cancer"},{"key":"1124_CR8","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1200\/JCO.2005.04.028","volume":"23","author":"SJ Katz","year":"2005","unstructured":"Katz SJ, Lantz PM, Janz NK et al (2005) Patterns and correlates of local therapy for women with ductal carcinoma-in situ. J Clin Oncol 23:3001\u20133007","journal-title":"J Clin Oncol"},{"key":"1124_CR9","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/00019606-200003000-00003","volume":"9","author":"MM Aubele","year":"2000","unstructured":"Aubele MM, Cummings MC, Mattis AE et al (2000) Accumulation of chromosomal imbalances from intraductal proliferative lesions to adjacent in situ and invasive ductal breast cancer. Diagn Mol Pathol 9:14\u201319","journal-title":"Diagn Mol Pathol"},{"key":"1124_CR10","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/0046-8177(92)90257-4","volume":"23","author":"DC Allred","year":"1992","unstructured":"Allred DC, Clark GM, Molina R et al (1992) Overexpression of HER-2\/neu and its relationship with other prognostic factors change during the progression of in situ to invasive breast cancer. Hum Pathol 23:974\u2013979","journal-title":"Hum Pathol"},{"key":"1124_CR11","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0959-8049(96)00368-1","volume":"33","author":"M Rudas","year":"1997","unstructured":"Rudas M, Neumayer R, Gnant MFX et al (1997) p53 protein expression, cell proliferation and steroid hormone receptors in ductal and lobular in situ carcinomas of the breast. Eur J Cancer 33:39\u201344","journal-title":"Eur J Cancer"},{"key":"1124_CR12","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1016\/S0002-9440(10)64672-X","volume":"158","author":"V Luzzi","year":"2001","unstructured":"Luzzi V, Holtschlag V, Watson MA (2001) Expression profiling of ductal carcinoma in situ by laser capture microdissection and high-density oligonucleotide arrays. Am J Pathol 158:2005\u20132010","journal-title":"Am J Pathol"},{"key":"1124_CR13","first-page":"2043","volume":"23","author":"A Seth","year":"2003","unstructured":"Seth A, Kitching R, Landberg G et al (2003) Gene expression profiling of ductal carcinomas in situ and invasive breast tumors. Anticancer Res 23:2043\u20132051","journal-title":"Anticancer Res"},{"issue":"Suppl 1","key":"1124_CR14","first-page":"S81","volume":"76","author":"DC Allred","year":"2002","unstructured":"Allred DC, Wu Y, Tsimelzon A et al (2002) The progression of DCIS to IBC: a cDNA expression microarray study. Breast Cancer Res Treat 76(Suppl 1):S81","journal-title":"Breast Cancer Res Treat"},{"key":"1124_CR15","first-page":"37","volume-title":"Ductal carcinoma in situ of the breast","author":"DC Allred","year":"2002","unstructured":"Allred DC (2002) Biologic characteristics of ductal carcinoma in situ. In: Silverstein MJ (ed) Ductal carcinoma in situ of the breast, 2nd edn. Lippincott Williams & Wilkins, Philadelphia, pp 37\u201348","edition":"2"},{"key":"1124_CR16","first-page":"215","volume":"11","author":"OT Lampejo","year":"1994","unstructured":"Lampejo OT, Barnes DM, Smith P, Millis RR (1994) Evaluation of infiltrating ductal carcinomas with a DCIS component: correlation of the histologic type of the in situ component with grade of the infiltrating component. Semin Diagn Pathol 11:215\u2013222","journal-title":"Semin Diagn Pathol"},{"key":"1124_CR17","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/(SICI)1096-9896(199912)189:4<521::AID-PATH472>3.0.CO;2-B","volume":"189","author":"H Buerger","year":"1999","unstructured":"Buerger H, Otterbach F, Simon R et al (1999) Different genetic pathways in the evolution of invasive breast cancer are associated with distinct morphological subtypes. J Pathol 189:521\u2013526","journal-title":"J Pathol"},{"key":"1124_CR18","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/jso.2930470302","volume":"47","author":"ER Fisher","year":"1991","unstructured":"Fisher ER, Leeming R, Anderson S et al (1991) Conservative management of intraductal carcinoma (DCIS) of the breast. J Surg Oncol 47:139\u2013147","journal-title":"J Surg Oncol"},{"key":"1124_CR19","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1002\/(SICI)1097-0142(20000215)88:4<946::AID-CNCR26>3.0.CO;2-5","volume":"68","author":"GF Schwartz","year":"2000","unstructured":"Schwartz GF, Solin L, Olivotto I et al (2000) Consensus conference on the treatment classification of ductal carcinoma in situ of the breast, April 22\u201325, 1999. Cancer 68:946\u2013954","journal-title":"Cancer"},{"key":"1124_CR20","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S0959-8049(05)80114-5","volume":"28","author":"MJ Silverstein","year":"1992","unstructured":"Silverstein MJ, Cohlan BF, Gierson ED et al (1992) Ductal carcinoma in situ: 228 cases without microinvasion. Eur J Cancer 28:630\u2013634","journal-title":"Eur J Cancer"},{"key":"1124_CR21","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1634\/theoncologist.2008-0203","volume":"14","author":"A Guerreri-Gonzaga","year":"2009","unstructured":"Guerreri-Gonzaga A, Botteri E, Rotmensz N et al (2009) Ductal intraepithelial neoplasia: postsurgical out come for 1267 woman cared for in one single institution over 10\u00a0years. Oncologist 14:201\u2013212","journal-title":"Oncologist"},{"key":"1124_CR22","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.ijrobp.2006.03.009","volume":"65","author":"GL Schmidt","year":"2006","unstructured":"Schmidt GL, Schmidt BD, Haffty BG (2006) Rationalization and regionalization of treatments for DCIS of the breast. Int J Radiat Oncol Biol Phys 65:1397\u20131403","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1124_CR23","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1200\/JCO.2008.18.3103","volume":"27","author":"HM Kuerer","year":"2008","unstructured":"Kuerer HM, Albarracin C, Yang NT et al (2008) DCIS: state of the science and roadmap to advance the field. J Clin Oncol 27:279\u2013288","journal-title":"J Clin Oncol"},{"key":"1124_CR24","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/(SICI)1097-0142(19990801)86:3<429::AID-CNCR11>3.0.CO;2-Y","volume":"86","author":"ER Fisher","year":"1999","unstructured":"Fisher ER, Dignam J, Tan-Chiu E et al (1999) Pathologic findings from the NSABP eight years update of protocol B-17: intraductal carcinoma. Cancer 86:429\u2013438","journal-title":"Cancer"},{"key":"1124_CR25","unstructured":"Allred DC (2005) Ductal carcinoma in situ of the breast: pathologic and biologic perspectives. American Society of Clinical Oncology 2005 educational book 41st annual meeting, May 13\u201317, pp 75\u201379"},{"key":"1124_CR26","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1007\/s10434-000-0656-y","volume":"7","author":"NQ Mirza","year":"2000","unstructured":"Mirza NQ, Vlastos G, Meric F et al (2000) Ductal carcinoma-in situ: long-term results of breast conserving therapy. Ann Surg Oncol 7:656\u2013664","journal-title":"Ann Surg Oncol"},{"key":"1124_CR27","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/S0140-6736(99)05036-9","volume":"353","author":"B Fisher","year":"1999","unstructured":"Fisher B, Dignam J, Wolmark N et al (1999) Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomized controlled trial. Lancet 353:1993\u20132000","journal-title":"Lancet"},{"key":"1124_CR28","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1200\/JCO.2001.19.8.2263","volume":"19","author":"N Bijker","year":"2001","unstructured":"Bijker N, Peterse JL, Duchateau L et al (2001) Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma in-situ: analysis of European organization for research and treatment of cancer trial 10853. J Clin Oncol 19:2263\u20132271","journal-title":"J Clin Oncol"},{"key":"1124_CR29","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1093\/jnci\/djg097","volume":"95","author":"K Kerlikowske","year":"2003","unstructured":"Kerlikowske K, Molinaro A, Cha I et al (2003) Characteristics associated with recurrence among women with ductal carcinoma in situ treated by lumpectomy. J Natl Cancer Inst 95:1692\u20131702","journal-title":"J Natl Cancer Inst"},{"key":"1124_CR30","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1056\/NEJM199905133401902","volume":"340","author":"MJ Silverstein","year":"1999","unstructured":"Silverstein MJ, Lagios MD, Groshen S et al (1999) The influence of margin width on local control of ductal carcinoma in situ of the breast. N Engl J Med 340:1455\u20131461","journal-title":"N Engl J Med"},{"key":"1124_CR31","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/sj.bjc.6605513","volume":"102","author":"J Thomas","year":"2010","unstructured":"Thomas J, Evans A, Macartney J et al (2010) Radiological and pathological side estimations of pure ductal carcinoma in situ of the breast: a review of 2564 cases from the Sloane Project. Br J Cancer 102:285\u2013293","journal-title":"Br J Cancer"},{"key":"1124_CR32","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.ijrobp.2008.12.014","volume":"75","author":"A Monteau","year":"2009","unstructured":"Monteau A, Sigal-Zafrani B, Kirova YM et al (2009) Ductal carcinoma in situ of the breast with close or focally involved margins following breast-conserving surgery: treatment with reexcision or radiotherapy with increased dosage. Int J Radiat Oncol Biol Phys 75:1021\u20131028","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1124_CR33","unstructured":"Radiation Therapy Oncology Group (2004) RTOG 98-04. Phase III trial of observation\u00a0\u00b1\u00a0tamoxifen vs. RT\u00a0\u00b1\u00a0tamoxifen for good risk ductal carcinoma in situ (DCIS) of the female breast"},{"key":"1124_CR34","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1093\/jnci\/djh164","volume":"96","author":"G Leonard","year":"2004","unstructured":"Leonard G, Swain S (2004) Ductal carcinoma in situ, complexities and challenges. J Natl Cancer Inst 96:906\u2013920","journal-title":"J Natl Cancer Inst"},{"key":"1124_CR35","doi-asserted-by":"crossref","first-page":"5319","DOI":"10.1200\/JCO.2009.21.8560","volume":"27","author":"LL Hughes","year":"2009","unstructured":"Hughes LL, Wang M, Page DL (2009) Local excision alone without irradiation for ductal carcinoma in situ of the breast: a trial of the Eastern Cooperative Oncology Group. J Clin Oncol 27:5319\u20135324","journal-title":"J Clin Oncol"},{"key":"1124_CR36","unstructured":"Harris JR (2005) Radiotherapeutic considerations for DCIS. In: American Society of Clinical Oncology. 2005 educational book 41st annual meeting, May 13\u201317, 2005, pp 69\u201374"},{"key":"1124_CR37","first-page":"1155","volume":"95","author":"E Vincens","year":"2008","unstructured":"Vincens E, Alves K, Lauratet B et al (2008) Margin status in ductal carcinoma in situ of the breast. Bull Cancer 95:1155\u20131159","journal-title":"Bull Cancer"},{"key":"1124_CR38","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/S1470-2045(06)70861-0","volume":"7","author":"K Mokbel","year":"2006","unstructured":"Mokbel K, Cutuli B (2006) Heterogeneity the ductal carcinoma in situ and its effects of managements. Lancet Oncol 7:756\u2013765","journal-title":"Lancet Oncol"},{"issue":"Suppl 3","key":"1124_CR39","doi-asserted-by":"crossref","first-page":"S84","DOI":"10.1016\/S0960-9776(09)70279-6","volume":"18","author":"M Morrow","year":"2009","unstructured":"Morrow M (2009) Breast conservation and negative margins: how much is enough? Breast 18(Suppl 3):S84\u2013S86","journal-title":"Breast"},{"key":"1124_CR40","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1200\/JCO.2008.17.5182","volume":"27","author":"C Dunne","year":"2009","unstructured":"Dunne C, Burke JP, Morrow M et al (2009) Effect of the margin status on local recurrence after breast conservation and radiation therapy for ductal carcinoma in situ. J Clin Oncol 27:1615\u20131620","journal-title":"J Clin Oncol"},{"key":"1124_CR41","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0960-9776(03)00151-6","volume":"12","author":"RE Mansell","year":"2003","unstructured":"Mansell RE (2003) Ductal carcinoma in situ: surgery and radiotherapy. Breast 12:447\u2013450","journal-title":"Breast"},{"issue":"8","key":"1124_CR42","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1093\/annonc\/mdp322","volume":"20","author":"A Goldhirsch","year":"2009","unstructured":"Goldhirsch A, Ingle JN, Gerlber RD et al (2009) Thresholds for the therapies: highlights of the Saint Gallen International Expert Consensus, on the primary therapy of early breast cancer. Ann Oncol 20(8):1319\u20131329","journal-title":"Ann Oncol"},{"key":"1124_CR43","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1056\/NEJM199306033282201","volume":"328","author":"B Fisher","year":"1993","unstructured":"Fisher B, Constantino J, Redmond C et al (1993) Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer. N Engl J Med 328:1581\u20131586","journal-title":"N Engl J Med"},{"key":"1124_CR44","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1634\/theoncologist.12-11-1276","volume":"12","author":"JC Boughey","year":"2007","unstructured":"Boughey JC, Gonzalez RJ, Bonner E et al (2007) Current treatment and clinical trial developments for ductal carcinoma in situ of the breast. Oncologist 12:1276\u20131287","journal-title":"Oncologist"},{"issue":"12","key":"1124_CR45","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1002\/cncr.21069","volume":"103","author":"ME Sanders","year":"2005","unstructured":"Sanders ME, Schuyler PA, Dupont MO, Page DL (2005) The natural history of low-grade DCIS of the breast in women treated by biopsy only revealed over 30\u00a0years long-terms follow-up. Cancer 103(12):2481\u20132484","journal-title":"Cancer"},{"key":"1124_CR46","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1200\/JCO.1998.16.4.1367","volume":"16","author":"MJ Silverstein","year":"1998","unstructured":"Silverstein MJ, Lagios MD, Martino S et al (1998) Outcome after invasive LR in patients with ductal carcinoma in situ of the breast. J Clin Oncol 16:1367\u20131373","journal-title":"J Clin Oncol"},{"key":"1124_CR47","first-page":"158","volume":"2","author":"LJ Solin","year":"1996","unstructured":"Solin LJ, McCormick B, Recht A et al (1996) Mammographically detected clinically occult ductal carcinoma in situ (intraductal carcinoma) treated with breast conserving surgery and definitive breast irradiation. Cancer J Sci Am 2:158\u2013165","journal-title":"Cancer J Sci Am"},{"key":"1124_CR48","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1001\/archinte.160.7.953","volume":"160","author":"VL Ernster","year":"2000","unstructured":"Ernster VL, Barclay J, Kerlikowske K et al (2000) Mortality among women with ductal carcinoma in situ of the breast in the population-based surveillance, epidemiology and end results program. Arch Intern Med 160:953\u2013957","journal-title":"Arch Intern Med"},{"key":"1124_CR49","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.amjsurg.2006.06.005","volume":"192","author":"LA Lee","year":"2006","unstructured":"Lee LA, Silverstein MJ, Chung CT et al (2006) Breast cancer specific mortality after invasive local recurrence in patients with duct carcinoma in site of the breast. Am J Surg 192:416\u2013419","journal-title":"Am J Surg"},{"key":"1124_CR50","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1002\/1097-0142(19950315)75:6<1310::AID-CNCR2820750613>3.0.CO;2-G","volume":"75","author":"ER Fisher","year":"1995","unstructured":"Fisher ER, Costantino J, Fisher B et al (1995) Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) protocol B-17. Intraductal carcinoma (ductal carcinoma in situ). Cancer 75:1310\u20131319","journal-title":"Cancer"},{"key":"1124_CR51","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1309\/WH9LA543NR76Y29J","volume":"128","author":"E Fisher","year":"2007","unstructured":"Fisher E, Land S, Seeda R et al (2007) Pathologic variables predictive of breast events in patients with DCIS. Am J Clin Pathol 128:86\u201394","journal-title":"Am J Clin Pathol"},{"key":"1124_CR52","first-page":"7","volume":"50","author":"E Mamounas","year":"1997","unstructured":"Mamounas E, Fisher B, Dingam J et al (1997) Effects of breast irradiation following lumpectomy in intraductal carcinoma (DCIS): updated results from NSABP B-17. Proc Soc Surg Oncol 50:7","journal-title":"Proc Soc Surg Oncol"},{"key":"1124_CR53","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1200\/JCO.2002.07.137","volume":"20","author":"FA Vicini","year":"2002","unstructured":"Vicini FA, Recht A (2002) Age at diagnosis and outcome for women with ductal carcinoma in situ of the breast. A critical review of the literature. J Clin Oncol 20:2736\u20132744","journal-title":"J Clin Oncol"},{"key":"1124_CR54","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1097\/PAS.0b013e3181b7cb7a","volume":"33","author":"LC Collins","year":"2009","unstructured":"Collins LC, Achacoso N, Nekhlyudof L (2009) Relationship between clinical and pathologic features of ductal carcinoma in situ and patient age: an analysis of 657 patients. Am J Surg Pathol 33:1802\u20131808","journal-title":"Am J Surg Pathol"},{"key":"1124_CR55","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/jso.21284","volume":"100","author":"A Turaka","year":"2009","unstructured":"Turaka A, Freedman GM, Li T et al (2009) Young age is not associated with increased local recurrence for DCIS treated by breast-conservation surgery and radiation. J Surg Oncol 100:25\u201331","journal-title":"J Surg Oncol"},{"key":"1124_CR56","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0960-9776(03)00153-X","volume":"12","author":"MJ Silverstein","year":"2003","unstructured":"Silverstein MJ, Buchanan C (2003) Ductal carcinoma in situ: USC\/Van Nuys Prognostic Index and the impact of margin status. Breast 12:457\u2013471","journal-title":"Breast"},{"key":"1124_CR57","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.ejca.2009.12.004","volume":"46","author":"G Farante","year":"2010","unstructured":"Farante G, Zurrida S, Galimberti V et al (2010) No more axillary dissection in patients with ductal intraepithelial neoplasia (DIN). Eur J Cancer 46:476\u2013478","journal-title":"Eur J Cancer"},{"key":"1124_CR58","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/BF02307025","volume":"2","author":"DP Winchester","year":"1995","unstructured":"Winchester DP, Menck HR, Osteen RT et al (1995) Treatment trends for ductal carcinoma in situ of the breast. Ann Surg Oncol 2:207\u2013213","journal-title":"Ann Surg Oncol"},{"key":"1124_CR59","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1245\/s10434-008-9947-5","volume":"15","author":"M Porembka","year":"2008","unstructured":"Porembka M, Abraham RL, Sefko JA et al (2008) Factors associated with lymph node assessment in DCIS: analysis of 1988\u20132002 seer data. Ann Surg Oncol 15:2709\u20132719","journal-title":"Ann Surg Oncol"},{"key":"1124_CR60","unstructured":"Bishop H, Kearins O, Lawrence G et al. (2008) Significant variation in the management of non invasive breast carcinoma in the UK: initial findings from the Sloane Project, a UK national prospective audit. In: Proceedings of the 9th annual meeting of the American Society of Breast Surgeons, April 30\u2013May 4, p 31"},{"key":"1124_CR61","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1038\/sj.bjc.6604968","volume":"100","author":"B Cutuli","year":"2009","unstructured":"Cutuli B, Lemanski C, Fourquet A et al (2009) Breast conserving surgery with or without radiotherapy vs mastectomy for ductal carcinoma in situ: French survey experience. Br J Cancer 100:1048\u20131054","journal-title":"Br J Cancer"},{"key":"1124_CR62","doi-asserted-by":"crossref","first-page":"207","DOI":"10.6004\/jnccn.2003.0019","volume":"1","author":"SB Edge","year":"2003","unstructured":"Edge SB, Sheldon DG (2003) Counterpoint: sentinel lymph node biopsy is not indicated for ductal carcinoma in situ. J Natl Compr Canc Netw 1:207\u2013212","journal-title":"J Natl Compr Canc Netw"},{"key":"1124_CR63","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s10434-000-0015-z","volume":"7","author":"S Pendas","year":"2007","unstructured":"Pendas S, Dauway E, Giuliano R et al (2007) Sentinel node biopsy in ductal carcinoma in situ patients. Ann Surg Oncol 7:15\u201320","journal-title":"Ann Surg Oncol"},{"key":"1124_CR64","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1002\/bjs.6162","volume":"95","author":"B Ansari","year":"2008","unstructured":"Ansari B, Ogston SA, Purdie CA et al (2008) Meta-analysis of sentinel node biopsy in ductal carcinoma in situ of the breast. Br J Surg 95:547\u2013554","journal-title":"Br J Surg"},{"key":"1124_CR65","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1001\/archsurg.138.3.309","volume":"138","author":"M Intra","year":"2003","unstructured":"Intra M, Veronesi P, Mazzarol G et al (2003) Axillary sentinel lymph node biopsy in patients with pure ductal carcinoma in situ of the breast. Arch Surg 138:309\u2013313","journal-title":"Arch Surg"},{"key":"1124_CR66","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/jso.20652","volume":"95","author":"HS Cody","year":"2007","unstructured":"Cody HS (2007) Sentinel lymph node biopsy for breast cancer: Indications, contraindications, and new directions. J Surg Oncol 95:440\u2013442","journal-title":"J Surg Oncol"},{"key":"1124_CR67","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1245\/s10434-007-9353-4","volume":"14","author":"TB Julian","year":"2007","unstructured":"Julian TB, Land SR, Fourchette V et al (2007) Is sentinel node biopsy necessary in conservately treated DCIS? Ann Surg Oncol 14:2202\u20132208","journal-title":"Ann Surg Oncol"},{"key":"1124_CR68","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.amjsurg.2007.08.057","volume":"196","author":"M Yi","year":"2008","unstructured":"Yi M, Krishnamurthy S, Kuerer HM et al (2008) Role of primary tumor characteristics in predicting positive sentinel lymph nodes in patients with ductal carcinoma in situ or microinvasive breast cancer. Am J Surg 196:81\u201387","journal-title":"Am J Surg"},{"key":"1124_CR69","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1245\/s10434-007-9610-6","volume":"15","author":"F Dominguez","year":"2008","unstructured":"Dominguez F, Golshan M, Black D et al (2008) SLN biopsy is important in mastectomy for DCIS. Ann Surg Oncol 15:268\u2013273","journal-title":"Ann Surg Oncol"},{"key":"1124_CR70","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1016\/j.ejca.2007.09.001","volume":"43","author":"M Intra","year":"2007","unstructured":"Intra M, Rotmentz N, Mattar D et al (2007) Unnecessary axillary node dissections in the sentinel lymph node era. Eur J Cancer 43:2664\u20132668","journal-title":"Eur J Cancer"},{"key":"1124_CR71","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.cursur.2004.09.011","volume":"62","author":"EA Mittendorf","year":"2005","unstructured":"Mittendorf EA, Arciero CA, Guttchell V et al (2005) Core biopsy diagnosis of ductal carcinoma in situ: an indication for sentinel lymph node biopsy. Curr Surg 62:253\u2013257","journal-title":"Curr Surg"},{"key":"1124_CR72","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/j.1365-2559.2008.03158.x","volume":"53","author":"ME El Sayed","year":"2008","unstructured":"El Sayed ME, Rakha WA, Reed J et al (2008) Predictive value of needle core biopsy diagnoses of lesions of uncertain malignant potential (B3) in abnormalities detected by mammographic screening. Hystopathology 53:650\u2013657","journal-title":"Hystopathology"},{"key":"1124_CR73","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1111\/j.1742-1241.2008.01867.x","volume":"62","author":"FA Sakr","year":"2008","unstructured":"Sakr FA, Bezu R, Raoust C et al (2008) The sentinel lymph node procedure for patients with preoperative diagnosis of ductal carcinoma in situ: risk factors for unsuspected invasive disease and for metastatic sentinel lymph nodes. Int J Clin Pract 62:1730\u20131735","journal-title":"Int J Clin Pract"},{"key":"1124_CR74","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.jamcollsurg.2004.11.012","volume":"200","author":"TW Yen","year":"2005","unstructured":"Yen TW, Hunt KK, Ross MI et al (2005) Predictors of invasive breast cancer of an initial diagnosis of DCIS. A guide in the selective use of sentinel lymph node biopsy in management of DCIS. J Am Coll Surg 200:516\u2013526","journal-title":"J Am Coll Surg"},{"key":"1124_CR75","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1746-1596-4-26","volume":"4","author":"O Fadare","year":"2009","unstructured":"Fadare O, Clement NF, Ghofrani M (2009) High and intermediate grade ductal carcinoma in situ of the breast: a comparison of pathologic features in core biopsies and excisions and an evaluation of core biopsy features that may predict a close of positive margin in the excision. Diagn Pathol 4:26\u201331","journal-title":"Diagn Pathol"},{"key":"1124_CR76","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.crad.2008.08.007","volume":"64","author":"EA O\u2019Flynn","year":"2009","unstructured":"O\u2019Flynn EA, Morel JC, Gonzales J et al (2009) Prediction of the presence of invasive disease from the measurement of extent of malignant micro-calcifications on mammography and ductal carcinoma in situ grade at core biopsy. Clin Radiol 64:178\u2013183","journal-title":"Clin Radiol"},{"key":"1124_CR77","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1136\/jcp.2008.061457","volume":"62","author":"B Doyle","year":"2009","unstructured":"Doyle B, al-Mudhaffer M, Kennedy MM et al (2009) Sentinel lymph node biopsy in patients with a needle core biopsy diagnosis of ductal carcinoma in situ: is it justified? J Clin Pathol 62:534\u2013538","journal-title":"J Clin Pathol"},{"key":"1124_CR78","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.amjsurg.2008.06.011","volume":"196","author":"CD Murphy","year":"2008","unstructured":"Murphy CD, Jones JL, Hughes Javid S et al (2008) Do sentinel node micrometastases predict recurrence risk in ductal carcinoma in situ and ductal carcinoma in situ with microinvasion? Am J Surg 196:566\u2013568","journal-title":"Am J Surg"},{"key":"1124_CR79","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1245\/s10434-007-9414-8","volume":"14","author":"K Moore","year":"2005","unstructured":"Moore K, Sweeney K, Wilson M et al (2005) Outcomes for women with DCIS and positive sentinel node: a multi-institutional audit. Ann Surg Oncol 14:2911\u20132917","journal-title":"Ann Surg Oncol"},{"key":"1124_CR80","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/j.1524-4741.2007.00543.x","volume":"14","author":"C Tunon-de-Lara","year":"2008","unstructured":"Tunon-de-Lara C, Giard S, Buttarelli M et al (2008) Sentinel node procedure is warranted in ductal carcinoma in situ with high risk of occult invasive carcinoma treated by mastectomy. Breast J 14:135\u2013140","journal-title":"Breast J"},{"key":"1124_CR81","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/jso.20581","volume":"94","author":"M Leidenius","year":"2006","unstructured":"Leidenius M, Salmenkivi K, von Smitten K et al (2006) Tumour-positive sentinel node findings in patients with ductal carcinoma in situ. J Surg Oncol 94:380\u2013384","journal-title":"J Surg Oncol"},{"key":"1124_CR82","unstructured":"NIH State-of-the-Science Conference Statement (2009) Diagnosis and management of DCIS. September 22\u201324"},{"key":"1124_CR83","unstructured":"Bryan J, Land S, Allred C et al. (2003) DCIS: evidence from randomized trials. Proceedings of the 8th international conference March 12\u201315, 2003, St Gallen, Switzerland. Breast 12(Suppl. 1):S9 (S24)"},{"key":"1124_CR84","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1200\/JCO.2006.06.1366","volume":"24","author":"N Bijker","year":"2006","unstructured":"Bijker N, Meijnen P, Peterse JL et al (2006) Breast-conserving treatment with or without radiotherapy in ductal carcinoma in situ: ten-year results of European organisation for research and treatment of cancer randomized phase III trial 10853\u2014a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotheraphy Group. J Clin Oncol 24:3381\u20133387","journal-title":"J Clin Oncol"},{"key":"1124_CR85","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0140-6736(03)13859-7","volume":"362","author":"J Houghton","year":"2003","unstructured":"Houghton J, George WD, Cuzick J et al (2003) UK Coordinating Committee on Cancer Research: radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: randomised controlled trial. Lancet 362:95\u2013102","journal-title":"Lancet"},{"key":"1124_CR86","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1080\/02841860600681569","volume":"45","author":"SO Emdin","year":"2006","unstructured":"Emdin SO, Grandstrand B, Ringberg A et al (2006) SwDCIS: radiotherapy after sector resection for ductal carcinoma in situ of the breast. Results of a randomized trial in a population offered mammography screening. Acta Oncol 45:536\u2013543","journal-title":"Acta Oncol"},{"key":"1124_CR87","unstructured":"Goodwin A, Parker S, Ghersi D et al. (2009) Post-operative radiotherapy for ductal carcinoma in situ of the breast. Cochrane Database Syst Rev (4):CD000563"},{"issue":"7","key":"1124_CR88","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1200\/JCO.2005.02.9975","volume":"24","author":"JS Wong","year":"2006","unstructured":"Wong JS, Kaelin CM, Troyan SL et al (2006) Prospective study of wide excision alone for ductal carcinoma in situ of the breast. J Clin Oncol 24(7):1031\u20131036","journal-title":"J Clin Oncol"},{"key":"1124_CR89","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1200\/JCO.2005.04.4610","volume":"24","author":"LJ Solin","year":"2006","unstructured":"Solin LJ (2006) Is excision alone adequate treatment for low-risk ductal carcinoma in situ of the breast? J Clin Oncol 24:1017\u20131019","journal-title":"J Clin Oncol"},{"key":"1124_CR90","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.jamcollsurg.2009.07.006","volume":"209","author":"M Silverstein","year":"2009","unstructured":"Silverstein M, Retch A, Lagios M et al (2009) Image-detected breast cancer: state-of-the-art diagnosis and treatment. Am Coll Surg 209:504\u2013520","journal-title":"Am Coll Surg"},{"key":"1124_CR91","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/S1470-2045(06)70765-3","volume":"7","author":"A Omlin","year":"2006","unstructured":"Omlin A, Amichetti M, Azria D et al (2006) Boost radiotherapy in young women with DCIS: a multicentre, retrospective study of the Rare Cancer Network. Lancet Oncol 7:652\u2013656","journal-title":"Lancet Oncol"},{"key":"1124_CR92","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.canrad.2008.07.005","volume":"12","author":"D Azria","year":"2008","unstructured":"Azria D, Auvray H, Barillot I et al (2008) Ductal carcinoma in situ: role of the boost. Cancer Radiother 12:571\u2013576","journal-title":"Cancer Radiother"},{"key":"1124_CR93","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.ijrobp.2009.02.031","volume":"74","author":"B Smith","year":"2009","unstructured":"Smith B, Douglas A, Buchholz TA et al (2009) Accelerated partial breast irradiation consensus statement from the American society for radiation oncology (ASTRO). Int J Rad Oncol Biol Phys 74:987\u20131001","journal-title":"Int J Rad Oncol Biol Phys"},{"key":"1124_CR94","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.amjsurg.2009.06.013","volume":"198","author":"M Keisch","year":"2009","unstructured":"Keisch M, Vicini F, Beitsch P et al (2009) American Society of Breast Surgeons Mammosite Radiation Therapy System registry trial: ductal carcinoma in situ subset analysis-4\u00a0year data in 194 treated lesions. Am J Surg 198:505\u2013507","journal-title":"Am J Surg"},{"key":"1124_CR95","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s10549-008-0304-y","volume":"117","author":"JY Petit","year":"2009","unstructured":"Petit JY, Veronesi U, Orecchia R et al (2009) Nipple sparing mastectomy with nipple areola intraoperative radiotherapy: 1001 cases of a five years experience at the European Institute of Oncology in Milan (EIO). Breast Cancer Res Treat 117:333\u2013338","journal-title":"Breast Cancer Res Treat"},{"key":"1124_CR96","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/j.1524-4741.2009.00758.x","volume":"15","author":"C Garcia-Etienne","year":"2009","unstructured":"Garcia-Etienne C, Cody H III, Dosa J et al (2009) Nipple-sparing mastectomy: initial experience at the Memorial Sloan-Kettering Cancer Center and a comprehensive review of literature. Breast J 15:440\u2013449","journal-title":"Breast J"},{"key":"1124_CR97","doi-asserted-by":"crossref","first-page":"4930","DOI":"10.1200\/JCO.2009.23.9996","volume":"27","author":"E Brachtel","year":"2009","unstructured":"Brachtel E, Rusby E, Michaelson J et al (2009) Occult nipple involvement in breast cancer: clinicopathologic findings in 319 consecutive mastectomy specimens. J Clin Oncol 27:4930\u20134932","journal-title":"J Clin Oncol"},{"issue":"Suppl 1","key":"1124_CR98","first-page":"S34","volume":"82","author":"NLP Barnes","year":"2003","unstructured":"Barnes NLP, Boland G, Davenport A et al (2003) A prospective study of estrogen and progesterone receptor status in ductal carcinoma-in situ. Breast Cancer Res Treat 82(Suppl 1):S34","journal-title":"Breast Cancer Res Treat"},{"issue":"11","key":"1124_CR99","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1093\/jnci\/95.11.779","volume":"95","author":"A Decensi","year":"2003","unstructured":"Decensi A, Robertson C, Viale G et al (2003) A randomized trial of low-dose tamoxifen on breast cancer proliferation and blood estrogenic biomarkers. J Natl Cancer Inst 95(11):779\u2013790","journal-title":"J Natl Cancer Inst"},{"issue":"27","key":"1124_CR100","doi-asserted-by":"crossref","first-page":"4201","DOI":"10.1200\/JCO.2006.09.4318","volume":"25","author":"A Decensi","year":"2007","unstructured":"Decensi A, Gandini S, Serrano D et al (2007) Randomized dose-ranging trial of tamoxifen at low doses in hormone replacement therapy users. J Clin Oncol 25(27):4201\u20134209","journal-title":"J Clin Oncol"},{"key":"1124_CR101","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1001\/jama.295.23.joc60074","volume":"295","author":"VG Vogel","year":"2006","unstructured":"Vogel VG, Costantino JP, Wickerham DL et al (2006) Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial. JAMA 295:2727\u20132741","journal-title":"JAMA"},{"key":"1124_CR102","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1002\/cncr.20085","volume":"100","author":"TW Yen","year":"2004","unstructured":"Yen TW, Hunt KK, Mirza NQ et al (2004) Physician recommendations regarding tamoxifen and patient utilization of tamoxifen after surgery for ductal carcinoma in situ. Cancer 100:942\u2013949","journal-title":"Cancer"},{"key":"1124_CR103","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jsbmb.2005.02.004","volume":"93","author":"A Howell","year":"2005","unstructured":"Howell A, Buzdar A (2005) Are aromatase inhibitors superior to antiestrogens? J Steroid Biochem Mol Biol 93:237\u2013247","journal-title":"J Steroid Biochem Mol Biol"},{"key":"1124_CR104","doi-asserted-by":"crossref","first-page":"18649","DOI":"10.1074\/jbc.M111415200","volume":"277","author":"K Subbaramaiah","year":"2002","unstructured":"Subbaramaiah K, Norton L, Gerald W et al (2002) Cyclooxygenase-2 is overexpressed in HER-2\/neu-positive breast cancer: evidence for involvement of AP-1 and PEA3. J Biol Chem 277:18649\u201318657","journal-title":"J Biol Chem"},{"key":"1124_CR105","first-page":"1676","volume":"62","author":"E Half","year":"2002","unstructured":"Half E, Tang XM, Gwyn K et al (2002) Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinomas in situ. Cancer Res 62:1676\u20131681","journal-title":"Cancer Res"},{"key":"1124_CR106","unstructured":"Lowenfels A (2008) Ductal carcinoma in situ: evolving strategies to optimal diagnosis and management. In: Proceedings of the 93rd annual clinical congress of the American College of Surgeons"},{"key":"1124_CR107","unstructured":"Neoadjuvant Herceptin for Ductal Carcinoma in Situ of the Breast. (2008) Clinical trials gov identifier NCT00496808"},{"issue":"2","key":"1124_CR108","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1200\/JCO.2005.08.028","volume":"23","author":"K Altundag","year":"2005","unstructured":"Altundag K (2005) Challenge in the treatment of estrogen-receptor-negative ductal carcinoma in situ. J Clin Oncol 23(2):357\u2013367","journal-title":"J Clin Oncol"},{"key":"1124_CR109","first-page":"122","volume":"62","author":"KC Chan","year":"2002","unstructured":"Chan KC, Knox WF, Gee JG et al (2002) Effect of epidermal growth factor receptor tyrosine kinase inhibition on epithelial proliferation in normal and premalignant breast. Cancer Res 62:122\u2013128","journal-title":"Cancer Res"},{"key":"1124_CR110","first-page":"1643","volume":"3","author":"JC Newby","year":"1997","unstructured":"Newby JC, Johnston SR, Smith IE et al (1997) Expression of epidermal growth factor receptor and c-erbB2 during the development of tamoxifen resistance in human breast cancer. Clin Cancer Res 3:1643\u20131651","journal-title":"Clin Cancer Res"},{"key":"1124_CR111","doi-asserted-by":"crossref","first-page":"11798","DOI":"10.1073\/pnas.93.21.11798","volume":"93","author":"Y Noguchi","year":"1996","unstructured":"Noguchi Y, Jungbluth A, Richards EC, Old LJ (1996) Effect of interleukin 12 on tumor induction by 3-methylcholanthrene. Proc Natl Acad Sci USA 93:11798\u201311801","journal-title":"Proc Natl Acad Sci USA"},{"key":"1124_CR112","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1172\/JCI17323","volume":"113","author":"T Iinuma","year":"2004","unstructured":"Iinuma T, Homma S, Noda T et al (2004) Prevention of gastrointestinal tumours based on adenomatous polyposis coli gene mutation by dendritic cell vaccine. J Clin Invest 113:1307\u20131317","journal-title":"J Clin Invest"},{"key":"1124_CR113","first-page":"6944","volume":"62","author":"JW Greiner","year":"2002","unstructured":"Greiner JW, Zeytin H, Anver MR, Schlom J (2002) Vaccine-based therapy directed against carcinoembryonic antigen demonstrates antitumor activity on spontaneous intestinal tumors in the absence of autoimmunity. Cancer Res 62:6944\u20136951","journal-title":"Cancer Res"},{"key":"1124_CR114","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.4049\/jimmunol.170.4.1980","volume":"170","author":"J Xia","year":"2003","unstructured":"Xia J, Tanaka Y, Koido S et al (2003) Prevention of spontaneous breast carcinoma by prophylactic vaccination with dendritic\/tumor fusion cells. J Immunol 170:1980\u20131986","journal-title":"J Immunol"},{"key":"1124_CR115","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1172\/JCI19850","volume":"113","author":"E Quaglino","year":"2004","unstructured":"Quaglino E (2004) Concordant morphologic and gene expression data show that a vaccine halts HER-2\/neu preneoplastic lesions. J Clin Invest 113:709\u2013717","journal-title":"J Clin Invest"},{"key":"1124_CR116","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/1097-0215(20000715)87:2<186::AID-IJC5>3.0.CO;2-1","volume":"87","author":"P Nanni","year":"2000","unstructured":"Nanni P, Pupa SM, Nicoletti G et al (2000) p185(neu) protein is required for tumor and anchorage-independent growth, not for cell proliferation of transgenic mammary carcinoma. Int J Cancer 87:186\u2013194","journal-title":"Int J Cancer"},{"key":"1124_CR117","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1158\/0008-5472.CAN-06-4038","volume":"64","author":"BJ Czerniecki","year":"2007","unstructured":"Czerniecki BJ, Koski GK, Koldowsky U et al (2007) Targeting Her-2\/new in early breast cancer development using dendritic cells with staged interleukin-12 burst excretion. Cancer Res 64:1842\u20131852","journal-title":"Cancer Res"},{"key":"1124_CR118","first-page":"155","volume":"44","author":"K Liang","year":"2003","unstructured":"Liang K, Jin W, Lu Y et al (2003) Targeting Her2 as an approach for sensitizing breast cancer cells to radiotherapy. Proc Am Assoc Cancer Res 44:155","journal-title":"Proc Am Assoc Cancer Res"},{"issue":"2","key":"1124_CR119","first-page":"145","volume":"46","author":"C Cicco De","year":"2002","unstructured":"De Cicco C, Pizzamiglio M, Trifir\u00f2 G et al (2002) Radioguided occult lesion localisation (ROLL) and surgical biopsy in breast cancer. Technical aspects. Q J Nucl Med 46(2):145\u2013151","journal-title":"Q J Nucl Med"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-010-1124-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-010-1124-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-010-1124-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T07:53:48Z","timestamp":1559462028000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-010-1124-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8,26]]},"references-count":119,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["1124"],"URL":"https:\/\/doi.org\/10.1007\/s10549-010-1124-4","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,8,26]]}}}